What's new

Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 9, Status: Authorised

Feb 9, 2025 - 22:26
 0
Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Plasma master file certificates

Next Article

Medicine shortages and availability issues

Related Posts

Summary of opinion: Porcilis ColiClos, 12/02/2025 Positive

Summary of opinion: Porcilis ColiClos, 12/02/2025 Positive

Feb 14, 2025  0

Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline

Guideline on quality, non-clinical and clinical require...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Ponvory, ponesimod, Date of authorisation: 19/05/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0